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Mutations in the chromatin-remodeling protein ATRX cause alpha thalassaemia and mental retar-
dation, but the severity of the disorder is independent of the specific mutation. In this issue of Cell,
Law et al. (2010) demonstrate that ATRX alters gene expression by binding to G-rich tandem
repeats, and the degree of transcriptional silencing caused by ATRX mutations correlates with
the number of repeats.The alpha thalassaemia/mental retarda-
tion syndrome X-linked gene, or ATRX,
encodes a large helicase protein involved
in maintaining chromatin structure. Pa-
tients with mutations in the ATRX gene
typically exhibit severe mental retardation,
development defects, and a blood disease
called alpha thalassaemia, characterized
by a deficiency in the alpha globin protein.
Approximately 113uniquemutations in the
ATRXgenehave been identified from>180
families, but exactly how these mutations
alter gene expression is not well under-
stood. Now Law et al. (2010) make signifi-
cant progress toward answering this
question by identifying where ATRX binds
in both the human and mouse genomes.
In addition, they provide an explanation
for why patients with identical mutations
in the ATRX gene display a broad variation
in phenotypes.
The ATRX gene encodes at least two
alternatively spliced transcripts that
give rise to slightly different proteins of
265 kDa and 280 kDa. The C-terminal
region contains a helicase/ATPase do-
main that shares sequence homology
with the Sucrose Non-Fermenting 2
(SNF2) family of chromatin-remodeling
enzymes (Gibbons et al., 1995). The
N-terminal region contains the ADD
(ATRX-DNMT3-DNMT3L) domain with a
plant homodomain zinc finger that may
interact with the tail of histone H3 (Argen-
taro et al., 2007). Mutations in ATRX that
cause alpha thalassaemia/mental retar-
dation syndrome X-linked or ATR-X
syndrome correlate with high sequence
conservation in these two domains, with
30% and50% of the mutations occur-
ring in the helicase/ATPase and ADD
domains, respectively.ATRX is known to interact with the
death domain-associated protein DAXX
(Xue et al., 2003). More recently, re-
searchers demonstrated that DAXX is a
histone chaperone with specificity for
the histone H3 variant, H3.3 (Drane
et al., 2010; Goldberg et al., 2010; Lewis
et al., 2010; Wong et al., 2010). Although
both ATRX and DAXX are required for
H3.3 incorporation at telomeres, H3.3
incorporation in coding regions and near
binding sites of transcription factors
depends on a different histone chap-
erone, called Hira (Goldberg et al., 2010).
Thus, it is still unclear what factors deter-
mine where ATRX and DAXX incorporate
H3.3.
The new findings by Law et al. make
great strides toward answering this
question. Previous immunofluorescence
studies found that ATRX preferentially
interacts with a number of repetitive
DNA sequences, such as arrays of DNA
encoding ribosomal RNA (i.e., rDNA
arrays), a Y-specific satellite, and a repeat
sequence adjacent to a telomere (PMID:
10742099). This led Law et al. to investi-
gate whether ATRX binds to other repeti-
tive elements across the genome. Many
standard genome-wide protocols pre-
clude such analysis because repetitive
DNA elements give rise to spurious false
positive signals, and thus these se-
quences are routinely removed from
study. To overcome this technical hurdle,
Law et al. adapt a chromatin immunopre-
cipitation sequencing approach (ChIP-
Seq) by normalizing the signal intensity
to the size of the repeat. This provides a
relatively unbiased view of ATRX binding
across the genome and reveals 1000
stringent targets for ATRX.Cell 143A key finding of this study is that, in both
human and mouse cells, the targets of
ATRX include CpG islands (i.e., regions
of the genomewith a high frequency of un-
methylated cytosine guanine dinucleo-
tides) and G-rich tandem repeats. Both
these DNA patterns are found at repeats
in telomeres, sequences adjacent to
telomeres (i.e., subtelomeric regions),
and rDNA. Moreover, Law and colleagues
show that ATRX predominantly binds to
G-rich tandem repeats in or near genes
that often display altered expression
patterns in patientswith ATR-X syndrome.
Law and colleagues found that, in
erythroid cells, ATRX strongly localizes
1 kb upstream of the alpha globin
gene HBM. This peak of ATRX binding
occurs within a tandem repeat, called
jz VNTR (CGCGGGGCGGGGG)n, where
the number of repeats (n) varies between
individuals. Interestingly, Law et al. find
that when ATRX is mutated, the most
downregulated genes in this gene cluster
are the alpha-like globin genes closest
to the jz VNTR repeat, and their down-
regulation scales with their proximity to
the ATRX binding site. The identification
of ATRX binding sequences within the
alpha globin gene cluster provides a direct
explanation as to why patients with
mutations in ATRX exhibit alpha thalas-
saemia.
Then Law and colleagues go a step
further and provide a molecular explana-
tion for how two individuals with the
same mutations in ATRX could have
different severities of alpha thalassaemia.
They demonstrate that patients with the
largest expansion of the jz VNTR repeat
have the greatest reduction in the expres-
sion of the alpha globin gene. At the, October 29, 2010 ª2010 Elsevier Inc. 335
Figure 1. Could ATRX Help to Convert G-Quadruplex DNA to Duplex DNA?
Some DNA sequences rich in guanine and cytosine nucleotides are capable of adopting a G4-quadruplex
configuration instead of the standard B-form duplex (left). The chromatin-remodeling protein ATRX binds
preferentially to DNA sequences that have the potential to form G4-quadruplexes (Law et al., 2010). ATRX
belongs to a family of proteins that can translocate along duplex DNA, which may help to convert
G4-quadruplexes to duplex DNA. ATRX also associates with a histone chaperone, DAXX, which can direct
the assembly of nucleosomes containing the histone variant H3.3 (middle). Nucleosome assembly may
then further stabilize DNA in a duplex configuration (right).extreme end of the spectrum, this ulti-
mately leads to a total silencing or ‘‘mono-
allelic expression’’ of the alpha globin
gene.
Some tandem repeat sequences that
are rich in guanine nucleotides assemble
into non-B-form structures called
G-quadruplexes or G4 DNA (Figure 1).
These structures form readily in vitro
and, once created, are very stable. Law
and colleagues note that 50% of the
ATRX target sequences are predicted to
likely adopt the G-quadruplex conforma-
tion, and they demonstrate that seven of
these target sequences do indeed form
G-quadruplex structures in isolation.
Moreover, ATRX preferentially binds to
the quadruplex structure over the B-form
DNA in vitro. These observations suggest
a model in which ATRX localizes to
specific regions of the genome through
its association to G-quadruplexes. Then
through its interaction with DAXX, ATRX
directs the incorporation of H3.3 into
that region of the genome (Figure 1).
However, this model is only a hypoth-
esis, and exactly what ATRX does at
these target sites is still a key question.
Several studies have shown that ATRX
can alter nucleosome structure (Lewis
et al., 2010; Xue et al., 2003), but this
does not rule out the possibility that the
primary substrate of the ATRX helicase336 Cell 143, October 29, 2010 ª2010 Elsevimotor is nonchromatin DNA. For example,
if ATRX removes DNA quadruplexes, the
association with DAXX might be sufficient
to promote chromatin assembly, which
could then stabilize a B-DNA conforma-
tion (Figure 1). Consistent with this hy-
pothesis, a recent study found that
lowering the levels of ATRX compromises
telomere integrity (Wong et al., 2010).
Another important question is, what is
the function of H3.3 at these ATRX target
sequences? Assembled onto DNA
throughout the cell cycle, H3.3 is a non-
replicative histone that is often consid-
ered a hallmark of transcriptionally active
chromatin in genetic regions. However,
H3.3 is also known to mark many impor-
tant regulatory DNA sequences, including
both active gene promoters and DNA
elements with insulator activity (Jin et al.,
2009). Interestingly, the presence of
H3.3 at sites directed by ATRX is required
for repression of transcription at telomeric
repeats (Goldberg et al., 2010). Further-
more, ATRX has additional links to repres-
sive chromatin. For example, it associates
with the heterochromatin proteins HP1a
and HP1b (Berube et al., 2000), and the
presence of these proteins at telomeres
is dependent on ATRX (Wong et al., 2010).
Together these results suggest that
perhaps ATRX and H3.3 maintain the
boundary between regions of transcrip-er Inc.tionally active chromatin and inactive
chromatin (i.e., heterochromatin). Loss of
ATRX may then result in the spreading of
heterochromatin along DNA, resulting in
the progressive silencing of nearby genes
in cis, such as the alpha globin cluster.
Such a scenario would also deplete the
effective concentration of the protein
factors necessary for the formation of
heterochromatin, providing a plausible
explanation for the defects in telomeric
silencing seen in cells with ATRX and
DAXXmutations. Clearly, the new findings
by Law and colleagues demonstrate that
repetitive DNA may be ‘‘simple’’ in terms
of DNA sequence, but functionally they
are anything but.REFERENCES
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